Obesity and Acute Pulmonary Embolism: Clinical Implications and Knowledge Gaps.

Obesity presents unique clinical challenges in the management of acute pulmonary embolism (PE), requiring a tailored approach to both diagnosis and treatment. However, current international guidelines offer limited guidance on specific strategies for managing PE in patients with obesity, often leaving clinicians with uncertainty. The coexistence of obesity and PE complicates diagnostic accuracy due to technical limitations and significantly influences both pharmacologic and interventional treatment decisions. Adding to this complexity is the "obesity paradox," whereby overweight and obese patients may exhibit better survival outcomes than those of normal weight, a phenomenon that complicates the understanding of PE pathophysiology and may contribute to the under-recognition of key risk factors for acute PE. This comprehensive overview offers a comprehensive analysis of the intricate relationship between obesity and PE, emphasizing pathophysiological mechanisms, clinical implications, diagnostic challenges, and evidence-based management approaches.

• Publication year

  2025

• Venue

  Journal of the American College of Cardiology

• Publication date

  2025-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2025.09.1504PMID 41224406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lower early mortality and risk prediction improvement of obesity after acute pulmonary embolism: results from a multicenter cohort analysis with external validation

  2025cited by this paper
• Pulmonary Embolism–Related Mortality in Patients With Cancer

  2025cited by this paper
• The outcomes of the obesity paradox in pulmonary embolism: a study of the national inpatient sample database from 2016 to 2020

  2025cited by this paper
• Impact of obesity on clinical outcomes in patients with high-risk pulmonary embolism: A comparative analysis

  2025cited by this paper
• Safety of Mechanical Thrombectomy in Obese Patients: Insights From a Single-Center Retrospective Analysis

  2024cited by this paper
• Pleural and pericardial effusions as prognostic factors in patients with acute pulmonary embolism: a multicenter study

  2024cited by this paper
• Obesity and cardiovascular disease: an ESC clinical consensus statement.

  2024cited by this paper
• Therapeutic Enoxaparin Dosing in Obesity

  2024cited by this paper
• Radiological findings and their relationship with mortality in acute pulmonary embolism.

  2024cited by this paper
• Utility of Dual-Energy Computed Tomography in Clinical Conundra

  2024cited by this paper
• The Obesity Mortality Paradox in Patients with Pulmonary Embolism: Insights from a Tertiary Care Center

  2024cited by this paper
• Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine

  2024cited by this paper
• Innovation in Catheter-Directed Therapy for Intermediate-High-Risk and High-Risk Pulmonary Embolism.

  2024cited by this paper
• International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence.

  2024cited by this paper
• Impact of Chronic Heart Failure on Acute Pulmonary Embolism in-Hospital Outcomes (From a Contemporary Study).

  2023cited by this paper
• Acute pulmonary embolism and cancer: findings from the COPE study

  2023cited by this paper
• Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

  2023cited by this paper
• Obesity Modifies Clinical Outcomes of Right Ventricular Dysfunction

  2023cited by this paper
• Epicardial adipose tissue as a prognostic marker in acute pulmonary embolism

  2023cited by this paper
• Obesity and Pulmonary Embolism: Can We Dismantle the “Obesity Paradox”

  2023cited by this paper
• Impact of venous thromboembolism on the mortality in patients with cancer: a population-based cohort study

  2023cited by this paper
• The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study

  2023cited by this paper
• Obesity as a Predictor for Pulmonary Embolism and Performance of the Age-Adjusted D-Dimer Strategy in Obese Patients with Suspected Pulmonary Embolism

  2023cited by this paper
• Visceral adiposity index and the risk of heart failure, late-life cardiac structure and function in ARIC Study.

  2023cited by this paper
• Strategies involving low-molecular-weight heparin for the treatment and prevention of venous thromboembolism in patients with obesity: A systematic review and meta-analysis

  2023cited by this paper
• Ultrasound-facilitated, catheter-directed thrombolysis versus anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study.

  2022cited by this paper
• Epicardial adipose tissue volume and CT-attenuation as prognostic factors for pulmonary embolism and mortality in critically ill patients affected by COVID-19

  2022cited by this paper
• Role of visceral fat areas defined by thoracic CT in acute pulmonary embolism

  2022cited by this paper
• Thrombolysis for massive pulmonary embolisms in morbid obesity: a multisite case–control study

  2021cited by this paper
• Quantification of pulmonary perfusion abnormalities using DCE-MRI in COPD: comparison with quantitative CT and pulmonary function

  2021cited by this paper
• Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE

  2021cited by this paper
• Adverse right ventricular remodelling, function, and stress responses in obesity: insights from cardiovascular magnetic resonance

  2021cited by this paper
• The Effect of Obesity on Echocardiographic Image Quality.

  2021cited by this paper
• Management of Obesity in Cardiovascular Practice: JACC Focus Seminar.

  2021cited by this paper
• A targeted proteomics investigation of the obesity paradox in venous thromboembolism.

  2021cited by this paper
• Unexpected Low Natriuretic Peptide Levels: Any Consequences in Acute Pulmonary Embolism Prognostication?

  2021cited by this paper
• Obesity: another ongoing pandemic

  2021cited by this paper
• Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

  2021cited by this paper
• Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and their cardiovascular benefits—The role of the GLP‐1 receptor

  2021cited by this paper
• Once-Weekly Semaglutide in Adults with Overweight or Obesity.

  2021cited by this paper
• Feasibility of Transthoracic Echocardiography in Obese Patients and Its Relation to the Distance between the Skin Surface and the Left Ventricular Apex.

  2020cited by this paper
• Unfractionated heparin infusion for treatment of venous thromboembolism based on actual body weight without dose capping

  2020cited by this paper
• Echocardiographic Imaging Challenges in Obesity: Guideline Recommendations and Limitations of Adjusting to Body Size

  2020cited by this paper
• Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?

  2020cited by this paper
• How I Treat Obese Patients with Oral Anticoagulants.

  2020cited by this paper
• Obesity Is Associated With Pulmonary Hypertension and Modifies Outcomes

  2020cited by this paper
• Unfractionated heparin dosing in obese patients

  2020cited by this paper
• Echocardiography in the Era of Obesity.

  2020cited by this paper
• Relationship between body mass index, risk of venous thromboembolism and pulmonary embolism: A systematic review and dose-response meta-analysis of cohort studies among four million participants.

  2020cited by this paper
• Weight-Adjusted Contrast Administration in the Computed Tomography Evaluation of Pulmonary Embolism.

  2020cited by this paper
• Pulmonary embolism in obesity‐hypoventilation syndrome

  2020cited by this paper
• Brain Natriuretic Peptide and Troponin T in Patients With Acute Pulmonary Embolism and Grade 3 Obesity: A Retrospective Analysis

  2020cited by this paper
• Left Ventricular Dysfunction Correlates With Mortality in Pulmonary Embolism.

  2020cited by this paper
• The Dynamic Platelet Transcriptome in Obesity and Weight Loss.

  2020cited by this paper
• Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review

  2020cited by this paper
• Pulmonary Embolism and Heart Failure: A Reappraisal

  2020cited by this paper
• Lung Scintigraphy in COPD.

  2019cited by this paper
• Obesity Paradox in Pulmonary Embolism: Myth or Reality?

  2019cited by this paper
• 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

  2019cited by this paper
• Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

  2019cited by this paper
• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2019cited by this paper
• Left atrial size measured on CT pulmonary angiography: another parameter of pulmonary embolism severity? A systematic review

  2019cited by this paper
• Abdominal visceral adipose tissue is associated with unsuspected pulmonary embolism on routine CT scans in patients with gastrointestinal cancer.

  2019cited by this paper
• Survival Benefit of Obese Patients With Pulmonary Embolism.

  2019cited by this paper
• Investigation of the Obesity Paradox in Chronic Obstructive Pulmonary Disease, According to Smoking Status, in the United States

  2019cited by this paper
• Technical challenges of imaging & image-guided interventions in obese patients.

  2018cited by this paper
• Imaging of suspected pulmonary embolism and deep venous thrombosis in obese patients.

  2018cited by this paper
• Body mass index and the risk of low femoral artery puncture in coronary angiography under fluoroscopy guidance

  2018cited by this paper
• The impact of post-pulmonary embolism syndrome and its possible determinants.

  2018cited by this paper
• Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study.

  2017cited by this paper
• Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.

  2016cited by this paper
• Health-related quality of life after pulmonary embolism: a cross-sectional study

  2016cited by this paper
• Collider Bias Is Only a Partial Explanation for the Obesity Paradox

  2016cited by this paper
• Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

  2016cited by this paper
• Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension: Results From an International Prospective Registry

  2016cited by this paper
• The Obesity Epidemic--Understanding the Disease and the Treatment.

  2016cited by this paper
• Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism

  2015cited by this paper
• The impact of body mass index on lower extremity duplex ultrasonography for deep vein thrombosis diagnosis.

  2015cited by this paper
• Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: A meta-analysis of randomized controlled trials

  2015cited by this paper
• Association Between the Metabolic Syndrome, Its Individual Components, and Unprovoked Venous Thromboembolism: Results of a Patient-Level Meta-Analysis

  2014cited by this paper
• Significance of main pulmonary artery dilation on imaging studies.

  2014cited by this paper
• Identification of intermediate-risk patients with acute symptomatic pulmonary embolism

  2014cited by this paper
• Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure.

  2014cited by this paper
• Biomarkers and acute coronary syndromes: an update.

  2014cited by this paper
• Mechanisms of thrombosis in obesity

  2013cited by this paper
• Obesity and right ventricular structure and function: the MESA-Right Ventricle Study.

  2012cited by this paper
• Elevated factor VIII levels and risk of venous thrombosis

  2012cited by this paper
• Dosing of Unfractionated Heparin in Obese Patients with Venous Thromboembolism

  2011cited by this paper
• Obesity and pulmonary embolism: the mounting evidence of risk and the mortality paradox.

  2011cited by this paper
• The paradox of low BNP levels in obesity

  2011cited by this paper
• Systematic review of the use of retrievable inferior vena cava filters.

  2011cited by this paper
• Difficulties in diagnosing pulmonary embolism in the obese patient: A literature review

  2011cited by this paper
• Effect of Obesity on the Pharmacokinetics of Drugs in Humans

  2010cited by this paper
• Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism.

  2010cited by this paper
• Quality of life in long-term survivors of acute pulmonary embolism.

  2010cited by this paper
• Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.

  2010cited by this paper
• Dual-energy computed tomography in pulmonary embolism.

  2010cited by this paper
• Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism.

  2010cited by this paper
• Predominance of left‐sided deep vein thrombosis and body weight

  2010cited by this paper
• Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism?: A Population-Based Case–Control Study

  2009cited by this paper

• Obesity significantly elevates thromboembolism risk in severe trauma, yet essential resuscitation with TXA and erythrocytes remains safe

  2026cites this paper
• Association between the body roundness index and all-cause mortality in patients with metabolic dysfunction- associated steatotic liver disease.

  2026cites this paper